Reyes Bernabé

12.9k total citations
92 papers, 1.1k citations indexed

About

Reyes Bernabé is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Reyes Bernabé has authored 92 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 53 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Reyes Bernabé's work include Lung Cancer Treatments and Mutations (42 papers), Lung Cancer Research Studies (35 papers) and Cancer Immunotherapy and Biomarkers (25 papers). Reyes Bernabé is often cited by papers focused on Lung Cancer Treatments and Mutations (42 papers), Lung Cancer Research Studies (35 papers) and Cancer Immunotherapy and Biomarkers (25 papers). Reyes Bernabé collaborates with scholars based in Spain, United States and Germany. Reyes Bernabé's co-authors include Amparo Sánchez-Gastaldo, Laura Boyero, Sonia Molina‐Pinelo, Luis Paz‐Ares, Fiona Blackhall, Delvys Rodríguez‐Abreu, Manuel Cobo, Bartomeu Massutí, Andrew J. Wallace and Nicholas Hickson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Reyes Bernabé

85 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Reyes Bernabé Spain	19	684	611	211	173	102	92	1.1k
Filippo Gustavo Dall’Olio Italy	13	610 0.9×	433 0.7×	178 0.8×	229 1.3×	136 1.3×	39	956
Álvaro Taus Spain	18	540 0.8×	408 0.7×	223 1.1×	227 1.3×	104 1.0×	63	874
Keita Kudo Japan	13	1.0k 1.5×	611 1.0×	173 0.8×	107 0.6×	193 1.9×	35	1.3k
Kaname Nosaki Japan	19	976 1.4×	913 1.5×	366 1.7×	256 1.5×	67 0.7×	91	1.4k
Daniel Lee South Korea	12	519 0.8×	631 1.0×	197 0.9×	100 0.6×	35 0.3×	35	850
Seiichi Kakegawa Japan	17	372 0.5×	567 0.9×	219 1.0×	211 1.2×	65 0.6×	52	915
Haruko Daga Japan	16	594 0.9×	611 1.0×	181 0.9×	182 1.1×	35 0.3×	92	911
Jose M. Pacheco United States	16	591 0.9×	485 0.8×	196 0.9×	148 0.9×	52 0.5×	39	800
Ryoji Kato Japan	13	1.2k 1.7×	711 1.2×	206 1.0×	98 0.6×	198 1.9×	24	1.4k
Hidenobu Ishii Japan	15	1.0k 1.5×	692 1.1×	166 0.8×	217 1.3×	185 1.8×	55	1.3k

Countries citing papers authored by Reyes Bernabé

Since Specialization

Citations

This map shows the geographic impact of Reyes Bernabé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reyes Bernabé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reyes Bernabé more than expected).

Fields of papers citing papers by Reyes Bernabé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reyes Bernabé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reyes Bernabé. The network helps show where Reyes Bernabé may publish in the future.

Co-authorship network of co-authors of Reyes Bernabé

This figure shows the co-authorship network connecting the top 25 collaborators of Reyes Bernabé. A scholar is included among the top collaborators of Reyes Bernabé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reyes Bernabé. Reyes Bernabé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Serna‐Blasco, Roberto, J.L. González-Larriba, Reyes Bernabé, et al.. (2025). 210P: Prognostic Value of minimal residual disease in the NADIM II trial. Journal of Thoracic Oncology. 20(3). S138–S139. 1 indexed citations

Remón, Jordi, Paolo Bironzo, Nicolas Girard, et al.. (2025). Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial. The Lancet Oncology. 26(9). 1215–1226. 1 indexed citations

Isla, Dolores, Rosa Álvarez, María José Domper-Arnal, et al.. (2024). Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis. Journal of Medical Economics. 27(1). 1379–1387. 3 indexed citations

Arriola, Edurne, Reyes Bernabé, Rosario García Campelo, et al.. (2023). Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non–Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers. JCO Precision Oncology. 7(7). e2200546–e2200546. 26 indexed citations

Boyero, Laura, Ana Salinas, Amparo Sánchez-Gastaldo, et al.. (2023). Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer. Cancers. 15(5). 1466–1466. 6 indexed citations

Isla, Dolores, J. Casal, Manuel Cobo, et al.. (2023). PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement. Journal of Clinical Medicine. 12(15). 5063–5063. 6 indexed citations

Aix, Santiago Ponce, Patricia Cozar, Reyes Bernabé, et al.. (2023). 1050P Sensitization to immunotherapy through manipulation of tumor transcription by lurbinectedin. Annals of Oncology. 34. S636–S636.

Bernabé, Reyes, et al.. (2023). Current and Emerging Treatment Options for Patients With Relapsed Small-cell Lung Carcinoma: A Systematic Literature Review. Clinical Lung Cancer. 24(3). 185–208. 14 indexed citations

Provencio, Mariano, Enric Carcereny, Rafael López Castro, et al.. (2023). Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study. Translational Lung Cancer Research. 12(10). 2113–2128. 7 indexed citations

10.

Álava, Enrique de, et al.. (2022). Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective. Expert Review of Pharmacoeconomics & Outcomes Research. 22(6). 1033–1042. 12 indexed citations

11.

Remón, Jordi, Reyes Bernabé, Pedro Diz Dios, et al.. (2022). SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021). Clinical & Translational Oncology. 24(4). 635–645. 7 indexed citations

12.

Majem, Margarita, Manuel Cobo, Dolores Isla, et al.. (2021). PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis. Journal of Clinical Medicine. 10(7). 1365–1365. 15 indexed citations

13.

Remón, Jordi, Nicolas Girard, Silvia Novello, et al.. (2021). PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients. Clinical Lung Cancer. 23(3). e243–e246. 24 indexed citations

14.

Boyero, Laura, et al.. (2020). Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy. Cancers. 12(12). 3729–3729. 66 indexed citations

15.

Boyero, Laura, Ana Salinas, Reyes Bernabé, et al.. (2020). The Roles of Imprinted SLC22A18 and SLC22A18AS Gene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small Cell Lung Cancer Patients. Cancers. 12(8). 2075–2075. 12 indexed citations

16.

Ponce, Santiago, Karl Brendel, David R. Spigel, et al.. (2020). 1793P RESILIENT part 1: Pharmacokinetics of second-line (2L) liposomal irinotecan in patients with small cell lung cancer (SCLC). Annals of Oncology. 31. S1038–S1039. 1 indexed citations

17.

Ciruelos, Eva, Dolores Isla, Rafael López‐López, et al.. (2019). Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer. European Journal of Cancer Care. 28(6). e13164–e13164. 19 indexed citations

18.

Provencio, Mariano, Enric Carcereny, Delvys Rodríguez‐Abreu, et al.. (2019). Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study). Translational Lung Cancer Research. 8(4). 461–475. 43 indexed citations

19.

Lomas, M., et al.. (2008). A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer. Clinical & Translational Oncology. 10(12). 817–825. 1 indexed citations

20.

Isla, Dolores, et al.. (2007). P3-095: Erlotinib in advanced squamous cell carcinoma of the lung. Journal of Thoracic Oncology. 2(8). S719–S719. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact